Business Description
ODI Pharma AB
ISIN : SE0013409760
Share Class Description:
XSAT:ODI: Ordinary SharesCompare
Compare
Traded in other countries / regions
ODI.Sweden6OD.Germany IPO Date
2020-01-23Description
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.23 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -7.4 | |||||
| 3-Year EPS without NRI Growth Rate | -7.7 | |||||
| 3-Year FCF Growth Rate | 1.3 | |||||
| 3-Year Book Growth Rate | -49.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.77 | |||||
| 9-Day RSI | 39.02 | |||||
| 14-Day RSI | 43.61 | |||||
| 6-1 Month Momentum % | 47.52 | |||||
| 12-1 Month Momentum % | 57.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | |||||
| Quick Ratio | 1.26 | |||||
| Cash Ratio | 0.5 | |||||
| Days Inventory | 22.53 | |||||
| Days Sales Outstanding | 42.83 | |||||
| Days Payable | 56.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 14.09 | |||||
| Operating Margin % | -8.09 | |||||
| Net Margin % | -12.01 | |||||
| FCF Margin % | -13.5 | |||||
| ROE % | -61.13 | |||||
| ROA % | -19.65 | |||||
| ROIC % | -28.74 | |||||
| ROC (Joel Greenblatt) % | -819.2 | |||||
| ROCE % | -38.88 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.23 | |||||
| PB Ratio | 29.93 | |||||
| Price-to-Tangible-Book | 30.43 | |||||
| EV-to-EBIT | -91.38 | |||||
| EV-to-EBITDA | -91.79 | |||||
| EV-to-Revenue | 6.97 | |||||
| EV-to-FCF | -53.27 | |||||
| Price-to-Net-Current-Asset-Value | 30.43 | |||||
| Earnings Yield (Greenblatt) % | -1.1 | |||||
| FCF Yield % | -1.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ODI Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 14.413 | ||
| EPS (TTM) (kr) | -0.106 | ||
| Beta | 0 | ||
| Volatility % | 42.95 | ||
| 14-Day RSI | 43.61 | ||
| 14-Day ATR (kr) | 0.323301 | ||
| 20-Day SMA (kr) | 7.4275 | ||
| 12-1 Month Momentum % | 57.84 | ||
| 52-Week Range (kr) | 2.88 - 8.15 | ||
| Shares Outstanding (Mil) | 15.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ODI Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ODI Pharma AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
ODI Pharma AB Frequently Asked Questions
What is ODI Pharma AB(XSAT:ODI)'s stock price today?
The current price of XSAT:ODI is kr7.00. The 52 week high of XSAT:ODI is kr8.15 and 52 week low is kr2.88.
When is next earnings date of ODI Pharma AB(XSAT:ODI)?
The next earnings date of ODI Pharma AB(XSAT:ODI) is 2024-08-29.
Does ODI Pharma AB(XSAT:ODI) pay dividends? If so, how much?
ODI Pharma AB(XSAT:ODI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers